JP2024516713A5 - - Google Patents

Info

Publication number
JP2024516713A5
JP2024516713A5 JP2023568216A JP2023568216A JP2024516713A5 JP 2024516713 A5 JP2024516713 A5 JP 2024516713A5 JP 2023568216 A JP2023568216 A JP 2023568216A JP 2023568216 A JP2023568216 A JP 2023568216A JP 2024516713 A5 JP2024516713 A5 JP 2024516713A5
Authority
JP
Japan
Application number
JP2023568216A
Other languages
Japanese (ja)
Other versions
JP2024516713A (ja
JPWO2022236142A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/028202 external-priority patent/WO2022236142A2/en
Publication of JP2024516713A publication Critical patent/JP2024516713A/ja
Publication of JPWO2022236142A5 publication Critical patent/JPWO2022236142A5/ja
Publication of JP2024516713A5 publication Critical patent/JP2024516713A5/ja
Pending legal-status Critical Current

Links

JP2023568216A 2021-05-07 2022-05-06 キメラ受容体およびその使用方法 Pending JP2024516713A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163185896P 2021-05-07 2021-05-07
US63/185,896 2021-05-07
US202163283147P 2021-11-24 2021-11-24
US63/283,147 2021-11-24
PCT/US2022/028202 WO2022236142A2 (en) 2021-05-07 2022-05-06 Chimeric receptors and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2024516713A JP2024516713A (ja) 2024-04-16
JPWO2022236142A5 JPWO2022236142A5 (https=) 2025-05-14
JP2024516713A5 true JP2024516713A5 (https=) 2025-05-14

Family

ID=83933024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023568216A Pending JP2024516713A (ja) 2021-05-07 2022-05-06 キメラ受容体およびその使用方法

Country Status (9)

Country Link
US (1) US20240173410A1 (https=)
EP (1) EP4334346A4 (https=)
JP (1) JP2024516713A (https=)
KR (1) KR20240004680A (https=)
AU (1) AU2022270717A1 (https=)
CA (1) CA3217614A1 (https=)
IL (1) IL308148A (https=)
TW (1) TW202309091A (https=)
WO (1) WO2022236142A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12264189B2 (en) 2018-10-31 2025-04-01 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
WO2020092736A1 (en) 2018-10-31 2020-05-07 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
EP4698564A2 (en) * 2023-04-17 2026-02-25 Senti Biosciences, Inc. Antigen-binding domains and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014014951A (es) * 2012-06-06 2015-03-13 Oncomed Pharm Inc Agentes aglutinantes que modulan la trayectoria hippo y sus usos.
WO2019024979A1 (en) * 2017-07-31 2019-02-07 Institute For Research In Biomedicine FUNCTIONAL DOMAIN ANTIBODIES IN THE ELBOW REGION
JP7682797B2 (ja) * 2019-03-20 2025-05-26 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア クローディン6二重特異性抗体
EP3962527A4 (en) * 2019-04-30 2023-11-01 Senti Biosciences, Inc. CHIMERIC RECEPTORS AND METHODS OF USE THEREOF
CN111378037B (zh) * 2020-06-01 2020-09-01 南京诺艾新生物技术有限公司 一种抗hIL-33人源化单抗及其应用

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13145U (https=)
BY13159U (https=)
BY13140U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13166U (https=)
BY13164U (https=)